Anticipation and AnalysisBarchart has maintained a 56% BUY all week, from a 40% BUY last week and a 40% SELL a month ago. The resistance levels are at $.465, $.48 and $.50. The strongest level of support is at $.43. Morningstar's Fair Value sp is at $.48 and its 1-star speculative valuation is $1.01.
Since the beginning of 2021 THRM has only closed below $.30 on 7 days. During the majority of this time the sp has been between $.35 and $.45. All the analyses revolves around this sp range or better suggesting most investors are anticipating positive news on both approvals and contracts. While the FDA EUA review period has varied, the whole point of this legislation was to fast track authorizations. Imho it would be surprising, particularly with the rising infection rates in the US and abroad, that this doesn't happen before the end of next week. Indications from Rob certainly indicate the expectation of a positive outcome.
GLTE!!!
In the meantime the bashers will bash and the day traders will trade for lunch money ...an unfortunate consequence of a stock that while still being fairly characterized as a speculative penny stock is also on spec and the "pieces of the puzzle" a stock with the potential to offer significant rewards for those patient enough to wait.